Overall, the
tetanus toxoid coverage among pregnant respondents of present study was satisfactory as 85% of pregnant women were vaccinated with atleast two doses of TT during their current pregnancy at health care facility which is higher than another local study which showed that
tetanus toxoid coverage was only 43% and such percentage is much lower than recommended by World Health Organization (WHO) i.e.
In this regard, other studies should be conducted aiming at determining the proportion of
tetanus toxoid immunization status of mothers by antibody testing to know the absolute proportion of mothers protected tetanus at birth.
In a November 2014 statement, the CDC said, "There is not, and never was, human chorionic gonadotropin (HCG) in any
Tetanus Toxoid (TT) vaccine used for tetanus prevention" by UNICEF or WHO.
Peripheral neuropathy following
tetanus toxoid administration.
Updated recommendations for use of
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.
INTRODUCTION: A 48 years old male married Hindu; assistant agriculture officer from Imphal attended Psychiatric OPD with the chief complaints of repeated checking of his house and its premise, repeated washing of hands, feet and clothes and injecting
tetanus toxoid almost every day for duration of five years.
Tetanus was well known to the ancients; Greek physician Aretaeus wrote in the first century ce, "Tetanus in all its varieties, is a spasm of an exceedingly painful nature, very swift to prove fatal, but neither easy to be removed." Active immunization with
tetanus toxoid was described in 1890, but cases continue to be reported (275 in the United States from 2001 through 2010), almost exclusively in persons who were never vaccinated or had not received a booster immunization in the previous 10 years.
Bingham, director of the rheumatology clinics at John Hopkins University in Baltimore, reported that relative to patients treated with methotrexate only, patients who were given rituximab plus methotrexate mount a comparable recall response to
tetanus toxoid, a measure of retained immunity.
A new tool is now available to assist in controlling pertussis: the
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap).
The
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed (Tdap) was licensed in June for use as a single-dose booster immunization in persons aged 11-64 and was previously recommended by ACIP for use in adolescents.
Those of us who were immunized in infancy received a triple vaccine, DPT, containing diphtheria, pertussis (whooping cough), and
tetanus toxoid. If first immunized in military service, we were given Td, a dual vaccine that omits the pertussis toxoid and contains a smaller amount of diphtheria toxoid, which can cause adverse reactions in adults.
They identified the compound in each step by measuring the ability of various fractions to inhibit the proliferation of immune cells stimulated with
tetanus toxoid.